Mablin en es it fr

Mablin Brand names, Mablin Analogs

Mablin Brand Names Mixture

  • None

Mablin Chemical_Formula


Mablin RX_link

Mablin fda sheet

Mablin FDA

Mablin msds (material safety sheet)

Mablin MSDS

Mablin Synthesis Reference

U.S. pat. 2,917,432(1959)

Mablin Molecular Weight

246.304 g/mol

Mablin Melting Point

287 oC

Mablin H2O Solubility

6.9E+004 mg/L

Mablin State


Mablin LogP


Mablin Dosage Forms

Solution; Tablet

Mablin Indication

For use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.

Mablin Pharmacology

Busulfan is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death.

Mablin Absorption

Completely absorbed from the gastrointestinal tract.

Mablin side effects and Toxicity

Signs of overdose include allergic reaction, unusual bleeding or bruising, sudden weakness or unusual fatigue, persistent cough, congestion, or shortness of breath; flank, stomach or joint pain; pronounced nausea, vomiting, diarrhea, dizziness, confusion, or darkening of the skin, chills, fever, collapse, and loss of consciousness.

Mablin Patient Information

Mablin Organisms Affected

Humans and other mammals